Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

HIV-1 integration in microglia (LM-PCR)

ABSTRACT: We performed LM-PCR in an infected microglia cell line (C20) to map HIV-1 integration sites. Our aim was to compare the IS obtained through this method with ChIP-seq, ATAC-seq, and RNA-seq data obtained in the uninfected cells, allowing the assessment of integration preferences.

ORGANISM(S): Homo sapiens

PROVIDER: GSE206255 | GEO | 2023/02/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

HIV-1 integration in microglia (LM-PCR)

Project description:HIV-1 integration in microglia (LM-PCR)

| PRJNA849916 | ENA

HIV-1 integration in microglia (RNA-seq)

Project description:We performed RNA-seq in a microglia cell line (C20). Our aim was to understand how expression in the uninfected state will impact integration site selection on microglia.

2023-02-20 | GSE208047 | GEO

HIV-1 integration in microglia (ChIP-seq)

Project description:We performed ChIP-seq in a microglia cell line (C20) to understand integration patterns of HIV-1. We characterised the uninfected epigenetic cellular landscape in order to assess how integration is affected by distinct chromatin states and to understand the features defining integration-permissible regions.

2023-02-20 | GSE205914 | GEO

HIV-1 integration in microglia (ATAC-seq)

Project description:We performed ATAC-seq in a microglia cell line (C20) to assess chromatin accessibility alterations upon HIV-1 infection in latent and active status in comparison with the uninfected status.

2023-02-20 | GSE205807 | GEO

HIV-1 integration in microglia (ChIP-seq of CTCF-KD/-NT)

Project description:We performed ChIP-seq in a microglia cell line (C20) upon CTCF-KD and CTCF-NT (wild-type) to understand the impact of CTCF loss on chromatin and HIV-1 integration pattern in the C20 cell line.

2023-02-20 | GSE220859 | GEO

Janibacter sp. LM strain:LM

Project description:Janibacter sp. LM strain:LM Genome sequencing

| PRJNA1108354 | ENA

LM resistance

Project description:The combination therapy of the Artemisinin-derivative Artemether (ART) with Lumefantrine (LM) (Coartem®) is an important malaria treatment regimen in many endemic countries. Resistance to Artemisinin has already been reported, and it is feared that LM resistance (LMR) could also evolve quickly. Therefore molecular markers which can be used to track Coartem®efficacy are urgently needed. Often, stable resistance arises from initial, unstable phenotypes that can be identified in vitro. Here we have used the Plasmodium falciparum multidrug resistant reference strain V1S to induce LMR in vitro by culturing the parasite under continuous drug pressure for 16 months. The initial IC50 (inhibitory concentration that kills 50% of the parasite population) was 24 nM. The resulting resistant strain V1SLM, obtained after culture for an estimated 166 cycles under LM pressure, grew steadily in 378 nM of LM; this corresponds to 15 times the IC50 of the parental strain. However, after two weeks of culturing V1SLM in drug-free medium, the IC50 returned to that of the initial, parental strain V1S. This transient drug tolerance was associated with major changes in gene expression profiles: when we explored V1SLM using the PFSANGER Affymetrix custom array, we identified 184 differentially expressed (DE) genes; amongst those 18 putative transporters including the multidrug resistance gene (pfmdr1), the multidrug resistance associated protein (pfmrp1) and the V-type H+ pumping pyrophosphatase 2 (pfvp2). Moreover, our results showed significant enrichment of genes associated with fatty acid metabolism and a clear selective advantage for two genomic loci in parasites grown under LM drug pressure, suggesting these genes may contribute to LM response in P. falciparum and could prove useful as molecular markers to monitor LM susceptibility.

2011-04-01 | E-TABM-1101 | biostudies-arrayexpress

Porphyrobacter sp. LM 6 strain:LM 6

Project description:Porphyrobacter sp. LM 6 strain:LM 6 Genome sequencing and assembly

| PRJNA340879 | ENA

Cerebrospinal fluid microRNA profile in leptomeningeal metastasis patients [LM vs non-LM]

Project description:Cerebrospinal fluid microRNA profile in leptomeningeal metastasis patients [LM vs non-LM]

| PRJNA515502 | ENA

scRNAseq of NT2.5 and NT2.5-LM breast tumors

Project description:Syngeneic NT2.5 and NT2.5-LM breast tumors established in female NeuN mice were collected and sent for scRNAseq to examine various cell populations

2024-06-30 | GSE261252 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data